Reta/Cagri Blend – 12.5mg/2.5mg
This research peptide blend contains 12.5mg of Retatrutide and 2.5mg of Cagrilintide in a lyophilized powder format. It is supplied in a single vial and is intended exclusively for laboratory-based scientific analysis.
Product Features
- Compound: Retatrutide + Cagrilintide
- Concentration: 12.5mg / 2.5mg
- Form: Freeze-dried (lyophilized) powder
- Packaging: Single vial
- Purity: ≥99%
Intended Use
This product is for research and development purposes only. It is not intended for human or veterinary use.
Storage & Handling
- Store at -20°C upon receipt
- Protect from light and moisture
Lab Results / COA
Previous Certificates of Analysis
- RETCAG1507102025-01 – Date: 16 JUL ’25
Additional Information
| Weight | .2 lbs |
|---|---|
| Dimensions | 2 × 2 × 2 in |
